Prenetics Global Limited

NASDAQ:PRE

Medical - Diagnostics & Research

Healthcare
$10.31 +2.19%

+$0.43 today

Market cap
$184.89M
Beta
0.24
P/E (TTM)
-4.9
EPS (TTM)
-$4.18
52W Low $7.18High $23.63

Volume 0.82M

Average 0.22M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$21.81M

FY 2025 · Annual

Investing Cash Flow

-$35.79M

FY 2025 · Annual

Financing Cash Flow

$37.54M

FY 2025 · Annual

Cash Flow Statement

USD
Metric
FY 2021
Dec 2021
FY 2022
Dec 2022
FY 2023
Dec 2023
FY 2024
Dec 2024
FY 2025
Dec 2025
Net Income(174.02M)(190.45M)(64.78M)(49.81M)(52.7M)
Depreciation & Amortization7.35M7.54M7.79M5.93M3.78M
Deferred Income Tax3.73M7.15M(385.84K)(7.87M)0
Stock-Based Compensation22.49M31.58M10.59M11.98M0
Change in Working Capital(6.59M)(33.76M)24.21M1.97M6.62M
Accounts Receivables(24.06M)6.97M37.63M(428K)(529K)
Inventory(2.33M)1.26M(1.73M)1.32M(3.38M)
Accounts Payables(3.46M)(2.63M)(5.62M)(4.68M)4.91M
Other Working Capital23.26M(39.36M)(6.08M)5.75M5.62M
Other Non-Cash Items160.45M192.46M8.8M8.93M20.48M
Operating Cash Flow13.42M14.51M(13.76M)(28.87M)(21.81M)
Capital Expenditures(11.41M)(6.34M)(911.81K)(1.07M)(208K)
Acquisitions (Net)0(3.42M)021.65M37.78M
Purchases of Investments(10M)(39.92M)(26M)(129K)(20M)
Sales of Investments03M19.92M16M0
Other Investing Activities(3.47M)531.99K(76.52M)2.02M1,000K
Investing Cash Flow(22.02M)(46.14M)(82.95M)38.54M(35.79M)
Debt Repayment(1.3M)(1.88M)(3.23M)(2.56M)40.15M
Common Stock Issued0116.86K2.17K02K
Common Stock Repurchased0(661.52K)(1.23M)(577K)0
Dividends Paid00000
Other Financing Activities4.65M145.86M(241.5K)(203K)(2.61M)
Financing Cash Flow29.32M143.32M(4.7M)(3.34M)37.54M
Effect of Forex Changes87.21K(317.47K)467.93K221K(65K)
Net Change in Cash20.8M111.37M(100.95M)6.55M(20.12M)
Free Cash Flow2M8.17M(14.68M)(29.94M)(22.02M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$52.7M
+ D&A$3.8M
+ Stock-Based Comp$0
+ Deferred Tax$0
+ Working Capital$6.6M
+ Other Non-Cash$20.5M
= Operating Cash Flow-$21.8M
- Capex-$208.0K
= Free Cash Flow-$22.0M

Analysis

FY2025 free cash flow is -$22.0M. FCF conversion is 41.8% of net income. Operating cash flow was -$21.8M, with capex of -$208.0K. The largest bridge item is Other Non-Cash at $20.5M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
6-K6-K filingNov 5, 2026
4Statement of changes in beneficial ownershipNov 5, 2026
6-K6-K filingNov 3, 2026
6-K6-K filingNov 2, 2026
6-K6-K filingOct 13, 2026

Does PRE generate free cash flow?

Prenetics Global Limited (PRE) generated -$22.02M of free cash flow in fiscal 2025.

How much operating cash flow does PRE produce?

Operating cash flow was -$21.81M, before capital expenditures of $208,000.00.